HRV Pharma buys Germany's Phatebo

New Delhi: Hyderabad-based HRV Pharma on Tuesday announced the acquisition of 100% equity stake in Germany-based Phatebo from ZeroStack.

HRV Pharma did not disclose the financial details of the deal, but said Phatebo posted revenues of about Rs 350 crore in 2025.

The acquisition marks virtual pharmaceutical company HRV's entry beyond active pharmaceutical ingredients (APIs) into finished formulations, giving it its first finished formulations business alongside a licenced operating entity in Germany.